The landscape of bispecific T cell engager in cancer treatment | Biomarker Research | Full Text
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers | ACS Synthetic Biology
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells: Molecular Therapy - Methods & Clinical Development
Imaging of Activated T Cells | Journal of Nuclear Medicine
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
A Synchronous IRF4-Dependent Gene Regulatory Network in B and Helper T Cells Orchestrating the Antibody Response: Trends in Immunology
Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation: Molecular Therapy
JCI - Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
T-cell Bispecific Antibodies | Genentech Oncology
An Introduction to Antibodies: Antigens, Epitopes and Antibodies
More on T Cells, Antibody Levels, and Our Ignorance | Science | AAAS
IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
Frontiers | γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Antibodies | Free Full-Text | Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm | Journal of Nuclear Medicine
T cell activation - Antineo
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection | Science Immunology
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity | The EMBO Journal
Antibodies + CAR-T Cells - Gene Center Munich - LMU Munich
Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing - Ontario COVID-19 Science Advisory Table
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
T Cell Immunity? | BioBus
Adaptive immunity and SARS-CoV-2
Not just antibodies: B cells and T cells mediate immunity to COVID-19 | Nature Reviews Immunology
Frontiers | Nanodrugs Targeting T Cells in Tumor Therapy
